Literature DB >> 8811587

Illicit use of ketamine in Scotland.

P J Dalgarno1, D Shewan.   

Abstract

Semistructured interviews were carried out with 20 illicit users of ketamine in Scotland. Participants had used a wide range of illegal drugs. Scottish drug agencies reported limited contact with ketamine users; however, subjects were knowledgeable regarding the licit purpose of ketamine, its effects, and its legal status. Ketamine was usually obtained through diversion from legitimate sources. Three participants reported extensive use, indicating the potential for psychological dependence. A standard dose of ketamine was typically 1/8 g, usually taken intranasally. Participants reported the ketamine experience as being extremely intense and dissociative, usually lasting for approximately one hour. All participants reported using ketamine in a carefully preplanned setting, emphasizing comfort, security, and familiarity. Participants identified potential problems arising from using ketamine in a public place, or in unfamiliar surroundings, and also suggested that novice users may encounter problems through lack of knowledge concerning the intense nature of the experience. Accurate information concerning the effects and nature of ketamine as well as the importance of set and setting should be made available. However, publicizing the drug should be avoided as widespread interest could cause greater problems than currently exist.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811587     DOI: 10.1080/02791072.1996.10524391

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  15 in total

1.  First injection of ketamine among young injection drug users (IDUs) in three U.S. cities.

Authors:  Stephen E Lankenau; Bill Sanders; Jennifer Jackson Bloom; Dodi Hathazi; Erica Alarcon; Stephanie Tortu; Michael C Clatts
Journal:  Drug Alcohol Depend       Date:  2006-09-18       Impact factor: 4.492

2.  Ecstasy and neurodegeneration. ...such as ketamine.

Authors:  D Shewan; P Dalgarno
Journal:  BMJ       Date:  1996-08-17

Review 3.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

4.  Patterns of polydrug use among ketamine injectors in New York City.

Authors:  Stephen E Lankenau; Michael C Clatts
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

5.  Raves: a review of the culture, the drugs and the prevention of harm.

Authors:  E Weir
Journal:  CMAJ       Date:  2000-06-27       Impact factor: 8.262

6.  Diabetes alters the blood glucose response to ketamine in streptozotocin-diabetic rats.

Authors:  Huayong Chen; Li Li; Hui Xia
Journal:  Int J Clin Exp Med       Date:  2015-07-15

7.  The role of setting in the oral self-administration of alcohol in the rat.

Authors:  Arianna Testa; Paolo Nencini; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2011-02-11       Impact factor: 4.530

8.  Ketamine impairs multiple cognitive domains in rhesus monkeys.

Authors:  Michael A Taffe; Sophia A Davis; Tannia Gutierrez; Lisa H Gold
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

Review 9.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

10.  Drug injection practices among high-risk youths: the first shot of ketamine.

Authors:  Stephen E Lankenau; Michael C Clatts
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.